This poster explains that implementing a PTCE training course for non-certified pharmacy technicians resulted in positive outcomes, shown by the pass rate and feedback from participants.

This poster explains how the CoP program improves disease state knowledge across the organization, leading to better patient outcomes through continuing education opportunities.

This poster highlights how implementing a standardized, collaborative method effectively facilitates specialty pharmacy accreditation, as shown by accreditation time and reaccreditation rate.

This poster explores how concentrated efforts to boost team morale and unity positively impact clinical teams working in a remote environment, helping pharmacists unite and grow as a community.

This poster explores how a professional mentorship program — such as Shields’ #ElevateMentorship program — strengthens company culture by building productive mentor-mentee relationships among coworkers and supporting personal and professional development.

This research poster examines the challenges in implementing programs to address social determinants of health (SDOH) within the pharmacy sector. It highlights the effectiveness of the Shields care model and patient management system in overcoming these barriers.

This research poster highlights that HSSP oncology patients had lower hospital utilization rates compared to a national network, indicating potential benefits of an integrated care model with close clinical monitoring and follow-up during the first three months of therapy.

This research poster explores the innovative clinical management model that was developed and implemented at four health system specialty pharmacies, allowing dispensing of ambrisentan, a specialty medication with a required REMS protocol.

This research poster examines how implementation of a pharmacy liaison-managed diabetes care model is associated with positive patients outcomes, including high PDC, HbA1c reductions, time to therapy initiation, and medication copays.

As we recognize amyotrophic lateral sclerosis (ALS) Awareness Month in May, the disease remains without a cure. A rare and fatal neurodegenerative disease characterized by a progressive degeneration of motor nerve cells in the brain and spinal cord,1 ALS leads